(redirected from N-Cadherin)
Also found in: Medical.
NCADNational College of Art and Design (Irish college)
NCADNew Cumberland Army Depot
NCADNoise Control and Acoustics Division (American Society of Mechanical Engineers)
NCADNotice of Cancellation At Anniversary Date (insurance/reinsurance)
NCADNorth Carolina Association of the Deaf
NCADNetwork Computer Aided Design (1997 trademark of NCAD Corporation; Erlanger, KY)
References in periodicals archive ?
To study the role of Sertoli-germ cell interactions in DBP-induced germ cell aggregation, we examined expression of cell-cell adhesion molecules, APC, espin, vimentin, and N-cadherin (Bartles et al.
Conversely, all esophageal adenocarcinomas (100%; 24 of 24) were negative with N-cadherin versus 42% of lung adenocarcinomas (10 of 24), which showed some staining.
N-Cadherin (neural cadherin) is associated with heightened invasive potential in cancer.
Scientists in Bristol have now produced a smaller, soluble form of N-cadherin that has the ability to stabilise plaques.
E-cadherin, which inhibits cancer cell migration and invasion, was reduced in B[a] P-treated groups relative to the control group, but expression of metastasis-promoting proteins, including N-cadherin, vimentin, snail, and slug, were induced after B[a]P exposure (Figure 2F).
In aggressive tumors, EMT is characterized by reduced expression of E-cadherin and increased N-cadherin expression, which contributes to a more stromal cellular adhesion profile and increased tumor cell motility and invasive properties.
The findings support a critical role for N-cadherin in pancreatic ductal adenocarcinma (PDA).
Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion.
This Phase II single agent trial, which is ongoing at the Ottawa Regional Cancer Centre, the Princess Margaret Hospital in Toronto and the Jewish General Hospital in Montreal, is designed to evaluate the anti-tumor activity and tolerability of repeated doses of ADH-1 in patients whose tumors express the molecular target N-cadherin.
The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas.
Comparison of Mesothelioma and Adenocarcinoma Procedure Mesothelioma Special stains Alcian blue + (hyaluronidase-sensitive) Colloidal iron + (hyaluronidase-sensitive) Mucicarmine -- Periodic acid--Schiff -- Immunohistochemistry Calretinin + Cytokeratin 5/6 + Thrombomodulin + HBME-1 + CD44S + N-cadherin + MOC13 -- BG-8 -- Carcinoembryonic antigen -- Leu-M1 (CD15) -- E-cadherin -- Ber-EP-4 -- B72.
E-cadherin was most frequently expressed (34/35, 97%), followed in frequency by N-cadherin (22/35, 63%) and P-cadherin (15/35, 43%).